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courses and the associated outcomes towards attitude formation.METHODS: In a
cross-sectional prospectively designed study a survey was self-administered to
second, third and final year doctorate of pharmacy students at a University with
diverse student body. The questionnaire included four sections: attitude, educa-
tion, knowledge and demographic. Pre-validated instruments were used to mea-
sure attitude towards herbal medications using a five-point likert scale while
knowledge was measured using a true-false scale. Descriptive statistics were used
to summarize data and multiple logistic regression was conducted to assess the
effect of pharmacy student’s herbal medication knowledge towards attitude for-
mation while controlling for age, race, sex, year of study, work experience and
herbal medication related courses. RESULTS: Of 206 students, 159 completed the
survey (response rate of 77.18%). Mean age of participants was 26 (3.2) years with
65.41% female and 81.13% had previous pharmacy work experience. The average
score on the herbal knowledge was 9.281.80 (maximum score of 15). Students
with higher knowledge hadpositive attitude towards herbalmedications (OR1.26;
95% CI1.01-1.57). Students with work experience had positive attitude towards
herbal medications (OR2.93; 95% CI1.05-8.14). However, 81% students believed
that they did not have sufficient knowledge of herbal medications and 91% stu-
dents reported that they neededmore information. CONCLUSIONS:Higher knowl-
edge leads to a positive attitude towards herbal medications among pharmacy
students indicating that they may recommend such products to patients. Evaluat-
ing the role of such recommendations to improve patients health outcomes is the
direction for the future.
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OBJECTIVES: The well-being of caregivers of children with chronic conditions can
be influenced by several aspects of their child’s care and their complex healthcare
needs. The objective of this study is to examine well-being and experiences of
caregivers of children with different chronic condition.METHODS: The study was
cross-sectional and used responses of caregivers of 19,423 children (aged 6-17
years) from the National Survey of Children’s Health, 2007. We created a hierarchy
of chronic conditions to classify children from our analytic sample in 6 mutually
exclusive groups: Autism SpectrumDisorder (ASD), Developmental delay/Learning
disability, Attention deficit hyperactivity disorder/behavioral problems, Depres-
sion/anxiety, Speech/hearing/vision problems, and Diabetes/asthma.We assessed
caregiverwell-being in three dimensions: physical health,mental health, and emo-
tional stress. Healthcare experiences were measured in two domains: Access
(health insurance adequacy and consistency; and unmet healthcare needs), Qual-
ity (family-centered care-FCC, and effective care-coordination-ECC). All analyses
adjusted for the for the complex survey design, to derive national estimates. Chi-
square tests, logistic and multinomial logistic regressions were performed in SAS
9.2. RESULTS: Physical health of caregivers was negatively affected by access to
care (unmet needs) and healthcare quality (lack of FCC). And poor mental health
was negatively associated with lack of ECC. As compared to caregivers of children
with asthma/diabetes, a higher percentage of caregivers with ASD children re-
ported poor physical health (26.6% vs 12.7%), poor mental health, and high emo-
tional stress (26.5% vs 2.1%). CONCLUSIONS: Child’s ASD places significant burden
on the caregiverwell-being, compared to other conditions. In addition to the type of
child’s disability and chronic condition, caregivers were at high risk for poor phys-
ical health and high emotional distress due to unmet needs for children’s health
and lower levels of the child’s healthcare quality.
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OBJECTIVES: With very few restrictions on choosing physicians under National
Health Insurance (NHI) program in Taiwan, patients could visit outpatient depart-
ments (OPD) in a tertiary medical facility to seek the primary care other than
secondary care. This study was to examine the impact of Integrated Medical Care
(IMC) services in China Medial University Hospital (CMUH), a 2000-bed medical
center, in Taiwan. METHODS: Those patients who made more than 50% of their
total OPD visits in Taiwan toward CMUH during January 2008 to June 2009 (baseline
period) were recognized as CMUH loyal patients. They were invited to utilize the
offered pluralistic IMC services, including integrated, geriatric and pharmaceutical
care clinics, in addition to usual primary and specialty clinics, during December
2009 toDecember 2010 (implementation period). Thosewhoused to visit one or two
specialists in CMUH were of the most interest. The computerized reminding and
medication utilization evaluation (MUE) systems were established to facilitate the
cooperative physician-clinical pharmacist medication therapy management
model. The medical and medication-related issues were reviewed by prescribers,
clinical pharmacists and the clinical MUE team as needed. The differences of med-
ical expenditure reimbursed by NHI, OPD visits, number of prescribed medication
(Rx) and emergency department (ED) visits in CMUH during baseline and imple-
mentation periods were examined. RESULTS: Of 11,902 loyal patients, 75% made
visits toward one or two specialties and otherwise. Themedical expenditures, OPD
visits, ED visits reduced 2.4%, 4.8% and 6.3% per person permonth,respectively, but
the number of Rx increased 0.2%. The differences of the health resources utiliza-
tion were reduced from the first to fourth quarter of implementation period.
CONCLUSIONS: There were positive outcomes of offering pluralistic IMC services.
However, the outcomes would be more significant across time if the IMC services
were emphasized more toward those who visited more than three specialists.
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OBJECTIVES: Frequently, technology appraisal decisions are based on the ICERs
estimated from economic models. The study objective was to investigate reasons
provided by three Health Technology Assessment authorities for acceptance of
high ICER submissions (commonly assumed threshold above £30,000) and rejection
of low ICER submissions (commonly assumed threshold below £30,000).
METHODS: All published technology appraisals since April 2005 were downloaded
from PBAC, SMC, and CADTH, websites. The manufacturer’s base-case ICERs were
extracted. Decision drivers provided by the agencies were extracted from the tech-
nology appraisals which were rejected despite a low ICER or accepted despite a
high ICER. RESULTS: The CADTH accepted 14 high ICER submissions; 71% owing to
stated clinical effectiveness, including 42% on the basis of restriction and 15%
restricted duration. The PBAC accepted 26 high ICER submissions; 53% owing to
stated cost-effectiveness, 30% with restriction, and 19% with a risk sharing agree-
ment. The SMC accepted 22 high ICER submissions; 68% owing to restriction, and
31% owing to orphan drug status. The CADTH rejected 2 low ICER submissions
owing to a lack of demonstrated clinical benefit. PBAC rejected 48 low ICER sub-
missions; 73% owing to lack of demonstrated clinical benefit, 40% owing to uncer-
tainty in the economic model, and and 27% owing to an unacceptably high ICER.
The SMC rejected 62 low ICER submissions; 34% owing to a lack of demonstrated
clinical efficacy, 71% owing to lack of a robust economic analysis, and 31% owing to
cost-effectiveness not being demonstrated. CONCLUSIONS: Aside from a demon-
stration of clinical and / or cost-effectiveness, high ICERs were accepted on the
basis of a restriction to certain patient groups, price reduction, or owing to orphan
drug status. Low ICER submissions were rejected on the basis of uncertain or lack-
ing clinical benefit, uncertain model estimates, or a lack of appropriate analysis.
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AHRQ VERSUS NICE: DO THE CONCLUSIONS IN CER REPORTS CORRESPOND
CLOSELY TO THE COMPARATIVE EFFECTIVENESS ASSESSMENTS MADE IN HTA
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OBJECTIVES: While non-US agencies such as NICE (National Institute for Health
and Clinical Excellence) in the UK have been conducting Health Technology As-
sessments (HTAs) for over ten years, Comparative Effectiveness Research (CER) as
conducted in the US is relatively recent. The lack of economic considerations is one
well-defined distinction between CER and HTA. The aim of this research is to
compare CER publications from AHRQ (Agency for Healthcare Research and Qual-
ity) with HTA-related publications fromNICE to determinewhether there are other
consistent, clear distinctions of note. METHODS: All 22 AHRQ CER publications
published on the National Institutes of Health website were assessed. Conclusions
relating to the comparative effectiveness of pharmaceuticals onmajor clinical out-
comes were compiled. The NICE website was searched for corresponding HTA
guidance, and conclusions and other features of the publications were compared.
RESULTS:Of the 14AHRQCERpublications that assessed pharmaceuticals, for only
two of these were there corresponding NICE HTAs. The CER publication on Rheu-
matoid Arthritis and Psoriatic Arthritis corresponded to two NICE HTAs, which
were both in general agreement with the CER report. In contrast, the conclusion
from the CER publication on Lipid-Modifying Agents stated that there was insuffi-
cient clinical evidence to guide decisions, whereas NICE was confident enough in
the evidence to make a subsequent access decision. In its Clinical Guideline (CG)
documentsNICE also provided statements relevant to three other AHRQCER report
topics; all were in general agreement with the AHRQ CER conclusions. The most
notable distinctions between CER and HTA reports, however, were in their scope,
breadth, and purpose. CONCLUSIONS:Where like-for-like comparisons were pos-
sible, this research found more agreement than disagreement between AHRQ and
NICE. Themajor distinctions of note related to the topics chosen for assessment by
the two agencies, which reflect differences in priorities between health systems.
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APPLYING FUZZY MULTIPLE CRITERIA DECISION MAKING TO ESTABLISH A
NEW HEALTH TECHNOLOGY ASSESSMENT SYSTEM WITH COVERAGE
IMPLICATIONS IN TAIWAN NATIONAL HEALTH INSURANCE
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OBJECTIVES: It became obvious that all countries consider health technology as-
sessment (HTA) differently due to the structure of individual health systems. The
objective of this study was to select and establish a new, proper HTA system in
Taiwan National Health Insurance.METHODS: A systematic literature review was
undertaken to identify relevant papers of each of short tandem polymorphism
analysis, positron emission tomography, photodynamic laser therapy and video-
assisted thoracic surgery and then used focus group discussion to select category’s
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